@article{bousmah:hal-03174666,
  TITLE = {{Cost-Utility Analysis of a Dolutegravir-Based Versus Low-Dose Efavirenz-Based Regimen for the Initial Treatment of HIV-Infected Patients in Cameroon (NAMSAL ANRS 12313 Trial)}},
  AUTHOR = {Bousmah, Marw{\^a}n-Al-Qays and Nishimwe, Marie Lib{\'e}r{\'e}e and Tovar-Sanchez, Tamara and Lantche Wandji, Martial and Mpoudi-Etame, Mireille and Maradan, Gwena{\"e}lle and Omgba Bassega, Pierrette and Varloteaux, Marie and Montoyo, Alice and Kouanfack, Charles and Delaporte, Eric and Boyer, Sylvie},
  URL = {https://hal.umontpellier.fr/hal-03174666},
  JOURNAL = {{PharmacoEconomics}},
  PUBLISHER = {{Springer Verlag}},
  VOLUME = {39},
  NUMBER = {3},
  PAGES = {331-343},
  YEAR = {2021},
  DOI = {10.1007/s40273-020-00987-3},
  PDF = {https://hal.umontpellier.fr/hal-03174666/file/Bousmah2021_Article_Cost-UtilityAnalysisOfADoluteg.pdf},
  HAL_ID = {hal-03174666},
  HAL_VERSION = {v1},
}